Rothschild Investment »

Design Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2026-03-31 $245 23 10.65

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Invesco Rafi Us 1000 Etf Etf (PRF)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Amazon Stock (AMZN)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Exxon Mobil Corp Stock (XOM)
Johnson & Johnson Stock (JNJ)
Capital Group Dividend Growers Etf Etf (CGDG)
Blackstone Stock (BX)
Abbvie Stock (ABBV)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding Design Therapeutics

Sr One Capital Management
RA Capital Management
Point72 Asset Management
Baker Bros. Advisors
BlackRock
Logos Global Management
Vanguard Group
Vivo Capital
Almitas Capital
Vanguard Capital Management
Driehaus Capital Management
Woodline Partners
Trails Edge Capital Partners
Kynam Capital Management
FMR

View all funds holding Design Therapeutics